From diagnosis to delivery: a retrospective analysis of diabetes in pregnancy at a tertiary care centre in South India
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20262122Keywords:
Gestational diabetes mellitus, Diabetes in pregnancy, Fetal growth restriction, Pre-eclampsia, Maternal outcomes, Neonatal outcomes, Tertiary care centreAbstract
Background: Diabetes in pregnancy is increasing globally, driven by rising obesity and lifestyle changes. In India, gestational diabetes mellitus (GDM) affects up to 15–20% of pregnancies and contributes substantially to obstetric and neonatal morbidities. Early identification and standardized management pathways are essential. Our objective is to review the clinical patterns, management strategies, and maternal–fetal outcomes of diabetic pregnancies, highlighting key trends useful for improving antenatal care pathways.
Methods: A retrospective descriptive study was conducted among 55 pregnant women diagnosed with diabetes and managed between January and December 2025 at a tertiary care institution in South India. Maternal demographic details, comorbidities, treatment modalities, obstetric complications, and pregnancy outcomes were obtained from medical records and analyzed descriptively.
Results: Most women were aged 20-30 years (50.9%) and were primiparous (74.5%). A family history of diabetes was present in 24 (43.6%). Diabetic pregnancies showed diverse comorbid profiles, with hypertensive disorders, thyroid dysfunction, and ART conception frequently co-existing. A significant proportion (81.8%) required pharmacologic therapy for diabetes. Growth abnormalities showed distinct maternal risk patterns LGA linked to endocrine immune factors, while FGR clustered around placental dysfunction (PE, PIH, ART, twins). A sizeable proportion (40%) delivered before term due to maternal or fetal indications, highlighting the need for anticipatory delivery planning. Delivery decisions were influenced predominantly by maternal complications and fetal status. Emergency LSCS was largely driven by pre-eclampsia and fetal distress, showing how rapidly clinical status can evolve in diabetic pregnancies.
Conclusion: Maternal and fetal outcomes in diabetic pregnancies are strongly influenced by associated comorbidities such as hypertensive disorders, hypothyroidism, and assisted conception. Early diagnosis, multidisciplinary antenatal surveillance, and individualized delivery planning are essential to improve pregnancy outcomes in diabetic women.
References
Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS. Brussels: International Diabetes Federation; 2021. Available at: https://www.ncbi.nlm.nih.gov /books/NBK581934/. Accessed on 14 March 2026.
Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004;52:707-11.
American Diabetes Association. Management of diabetes in pregnancy. Diabetes Care. 2024;47:S254-66.
HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.
Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016;354:i4694.
McIntyre HD, Kampmann U, Dalsgaard Clausen T, Laurie J, Ma RCW. Gestational Diabetes: An Update 60 Years After O'Sullivan and Mahan. J Clin Endocrinol Metab. 2024;110(1):e19-31.
Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022;43(5):763-93.
Goyal A, Gupta Y. Current approach to early gestational diabetes mellitus: A clinical update. Diabetes Metab Syndr. 2025;19(6):103256.
Kingdom J, Ashwal E, Lausman A, Liauw J, Soliman N, Figueiro-Filho E, et al. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies. J Obstet Gynaecol Can. 2023;45(10):102154.
Chew LC, Osuchukwu OO, Reed DJ, et al. Fetal Growth Restriction. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
American Diabetes Association Professional Practice Committee. Management of diabetes in pregnancy: Standards of Care in Diabetes—2025. Diabetes Care. 2025;49:S321-44.
Albairmani RA, Basheer BM, Macky MM, Al Syouti T, AlZubaidy H, Elfaki E, et al. Management of Diabetes in Pregnancy: A Review of Clinical Guidelines and Practices. Cureus. 2025;17(2):e79334.
Villalaín C, Herraiz I, Akolekar R, Figueras F, Crispi F, Rizzo G, et al Clinical practice guidance for the management of fetal growth restriction: an expert review. J Matern Fetal Neonatal Med. 2025;38(1):2526111.
SIGN Guideline 171. Management of diabetes in pregnancy. Scottish Intercollegiate Guidelines Network; 2023. Available at: https://www.sign.ac.uk /media/2205/sign-171-management-of-diabetes-in-pregnancy.pdf. Accessed on 14 March 2026.
Downloads
Published
How to Cite
Issue
Section
